07/22/2025
4:16 PM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T/A | |
07/22/2025
4:17 PM | Verve Therapeutics (Subject)
| Form SC 14D9/A | |
07/15/2025
5:14 AM | Verve Therapeutics (Subject)
| Form SC 14D9/A | |
07/15/2025
5:16 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2025
5:04 AM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T/A | |
06/25/2025
6:00 AM | Verve Therapeutics (Subject)
| Form SC 14D9 | |
06/25/2025
5:10 AM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T | |
06/17/2025
6:18 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:17 PM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
11:15 PM | Verve Therapeutics (Filer)
| Form EFFECT | |
05/14/2025
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for VERV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
6:45 AM | Verve Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:48 AM | Verve Therapeutics (Filer)
| Form ARS | |
04/25/2025
6:30 AM | Verve Therapeutics (Filer)
| Form DEF 14A | |
04/17/2025
4:40 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:57 AM | Verve Therapeutics (Filer)
| Form POS AM | |
02/27/2025
7:16 AM | Verve Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:45 AM | Verve Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:24 AM | Verve Therapeutics (Filer)
| Form POSASR | |
02/27/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:53 AM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/10/2025
8:24 PM | ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
8:00 AM | Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Lister Troy (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Politi Jason (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:30 PM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
12:52 PM | VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024
12:06 PM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
09/09/2024
3:36 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
08/08/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
A grave, grave error. (Ad) Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history.
But one analyst who predicted the collapse of Fannie Mae and GM says the AI giant is now headed for a brutal crash… and it could hit as soon as this year. Watch his urgent Nvidia exposé before it’s too late |
